Europe Cardiovascular Digital Solutions Market

Europe Cardiovascular Digital Solutions Market Size, Share & Industry Trends Analysis Report By Service Type, By End-use, By Deployment (Cloud-Based and On-premise), By Components (Devices and Software), By Country and Growth Forecast, 2022 - 2028

Report Id: KBV-13738 Publication Date: February-2023 Number of Pages: 100
Special Offering:
Industry Insights | Market Trends
Highest number of Tables | 24/7 Analyst Support

Market Report Description

The Europe Cardiovascular Digital Solutions Market would witness market growth of 4.1% CAGR during the forecast period (2022-2028).

Digital solutions are frequently used in healthcare to track the spread of infectious illnesses, monitor the quality of patient care, and evaluate clinical support. Utilizing cardiovascular digital solutions improves patient care through improved health monitoring, more individualized patient care, and decreased inefficiencies. The future of healthcare technology is bright because of digital innovations like wearable technology, telemedicine, and virtual reality technologies.

An example of a wearable gadget that could be utilized to assist in the management of CVD is a fitness tracker. Additionally, a home-based wearable constant ECG monitoring patch was successfully used by the mSToPS RCT to identify individuals with atrial fibrillation. The Apple Heart Study showed that the Apple Watch is only moderately good at detecting atrial fibrillation in its users. The EXPERT stands for Exercise Prescription in Everyday Practice & Rehabilitation Training. This tool illustrates a clinical electronic decision support tool.

EXPERT was developed by the European Association for Preventive Cardiology (EAPC) as an interactive decision tool that enables medical professionals to use an algorithm to compare their exercise recommendations to specified patient instances. Similarly, a customized EHR-based warning system could enhance the use of medication for heart failure that is prescribed according to guidelines, as demonstrated by the recent PROMPT-HF trial. The automatic interpretation of medical imaging data can also be helped by artificial intelligence decision-support tools.

Pharmaceutical companies are also engaged in the development of effective medications to address the rise in cardiac problems. The European Medicines Agency has prepared a complete overview of the current guidelines and possibilities for participation during the development phase of a medicinal product (EMA). The agency aims to provide scientific and regulatory assistance for the development of application materials as well as a smooth validation and assessment procedure. Other nations, like the UK, Germany, and Denmark, where regulatory authorities have developed legislation relating to digital pharmaceuticals and digital health solutions, have seen a similar rise. In addition, the requirement for digital solutions is predicted to expand, given the present activity in this region and the rising need for such solutions.

The Germany market dominated the Europe Cardiovascular Digital Solutions Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $8,345.3 Million by 2028. The UK market is estimated to grow a CAGR of 3.3% during (2022 - 2028). Additionally, The France market would experience a CAGR of 4.9% during (2022 - 2028).

Based on Service Type, the market is segmented into Unobtrusive Testing, CVD Health Informatics, Cardiac Rehab Programs and Others. Based on End-use, the market is segmented into Hospitals & Clinics, Ambulatory Care Centers and Others. Based on Deployment, the market is segmented into Cloud-Based and On-premise. Based on Components, the market is segmented into Devices and Software. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

Free Valuable Insights: The Global Cardiovascular Digital Solutions Market will Hit $128.1 Billion by 2028, at a CAGR of 4.8%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Apple, Inc., General Electric Company, Koninklijke Philips N.V., Verily Life Sciences LLC (Alphabet, Inc.), iRhythm Technologies, Inc., Bardy Diagnostics, Inc. (Hill-Rom Holdings Inc) (Baxter International Inc.), eviCore Healthcare (Express Scripts Holding Company) (Cigna Corporation), AliveCor, Inc., Cardiotrack, and HeartFlow, Inc.

Scope of the Study

Market Segments Covered in the Report:

By Service Type

  • Unobtrusive Testing
  • CVD Health Informatics
  • Cardiac Rehab Programs
  • Others

By End-use

  • Hospitals & Clinics
  • Ambulatory Care Centers
  • Others

By Deployment

  • Cloud-Based
  • On-premise

By Components

  • Devices
  • Software

By Country

  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Key Market Players

List of Companies Profiled in the Report:

  • Apple, Inc.
  • General Electric Company
  • Koninklijke Philips N.V.
  • Verily Life Sciences LLC (Alphabet, Inc.)
  • iRhythm Technologies, Inc.
  • Bardy Diagnostics, Inc. (Hill-Rom Holdings Inc) (Baxter International Inc.)
  • eviCore Healthcare (Express Scripts Holding Company) (Cigna Corporation)
  • AliveCor, Inc.
  • Cardiotrack
  • HeartFlow, Inc.
Need a report that reflects how COVID-19 has impacted this market and its growth? Download Free Sample Now


Call: +1(646) 600-5072


  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities

Unique Offerings Unique Offerings

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Support with 10% customization free after sale

Trusted by over
5000+ clients

Our team of dedicated experts can provide you with attractive expansion opportunities for your business.

Client Logo